Triethylamine → HCID 21942432, compound
Reaction equation
[F:1][C:2]([F:15])([F:14])[S:3]([O:6]S(C(F)(F)F)(=O)=O)(=[O:5])=[O:4].C(N(CC)CC)C.[N:23]1[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=1[C:29]1[N:33]=[C:32]([C:34]2[CH:39]=[C:38](O)[CH:37]=[C:36]([C:41]#[N:42])[CH:35]=2)[O:31][N:30]=1>ClCCl>[N:23]1[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=1[C:29]1[N:33]=[C:32]([C:34]2[CH:39]=[C:38]([O:6][S:3]([C:2]([F:15])([F:14])[F:1])(=[O:5])=[O:4])[CH:37]=[C:36]([C:41]#[N:42])[CH:35]=2)[O:31][N:30]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
Trifluoromethanesulfonic anhydride (22.9 μL, 0.14 mmol) and triethylamine (23.7 μL, 0.17) were added under argon to a vial containing 3-(2-pyridyl)-5-(3-cyano-5-hydroxyphenyl)-1,2,4-oxadiazole (30 mg, 0.11 mmol) in dichloromethane (1 mL). The vial was then sealed and the reaction was left stirring overnight at ambient temperature. The reaction mixture was placed directly onto a flash column and purified by eluting with hexanes:ethyl acetate:dichloromethane 3.5:0.5:4 to afford 11 mg (25%) of 3-(2-pyridyl)-5-(3-cyano-5-(trifluoromethylsulfonyloxy)phenyl) -1,2,4-oxadiazole: 1H NMR (CDCl3), δ (ppm): 8.88 (d, 1H), 8.63 (s, 1H), 8.44 (s, 1H), 8.24 (d, 1H), 7.93 (t, 1H), 7.83 (s, 1H), 7.52 (m, 1H).
Workup
- customThe vial was then sealed
- waitthe reaction was left
- custompurified
- washby eluting with hexanes:ethyl acetate:dichloromethane 3.5:0.5:4
Sources & evidence
- ORD record
- ord-79463ac96a8440cd86c88a83b87dfd36
- Source dataset
- uspto-grants-2003_12
- Patent number
- US06660753B2
Reaction notes
Loading…